UniProt ID | ILK_HUMAN | |
---|---|---|
UniProt AC | Q13418 | |
Protein Name | Integrin-linked protein kinase | |
Gene Name | ILK | |
Organism | Homo sapiens (Human). | |
Sequence Length | 452 | |
Subcellular Localization |
Cell junction, focal adhesion . Cell membrane Peripheral membrane protein Cytoplasmic side . Cell projection, lamellipodium . Cytoplasm, myofibril, sarcomere . |
|
Protein Description | Receptor-proximal protein kinase regulating integrin-mediated signal transduction. [PubMed: 8538749] | |
Protein Sequence | MDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAKAPLRELLRERAEKMGQNLNRIPYKDTFWKGTTRTRPRNGTLNKHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQCPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVCKLMKICMNEDPAKRPKFDMIVPILEKMQDK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDDIFTQC -------CCHHHHHC | 10.62 | 22223895 | |
20 | Ubiquitination | AVAVRLWLDNTENDL EEEEEEEEECCCCCC | 4.27 | - | |
31 | Ubiquitination | ENDLNQGDDHGFSPL CCCCCCCCCCCCCHH | 34.66 | - | |
36 | Ubiquitination | QGDDHGFSPLHWACR CCCCCCCCHHHHHHH | 31.01 | - | |
47 | Phosphorylation | WACREGRSAVVEMLI HHHHCCHHHHHHHHH | 35.95 | 20068231 | |
50 | Ubiquitination | REGRSAVVEMLIMRG HCCHHHHHHHHHHCC | 3.42 | - | |
57 | Ubiquitination | VEMLIMRGARINVMN HHHHHHCCCEEEEEC | 11.22 | - | |
64 | Ubiquitination | GARINVMNRGDDTPL CCEEEEECCCCCCCH | 40.27 | - | |
69 | Phosphorylation | VMNRGDDTPLHLAAS EECCCCCCCHHHHHH | 32.27 | - | |
75 | Ubiquitination | DTPLHLAASHGHRDI CCCHHHHHHCCCHHH | 14.39 | - | |
76 | Phosphorylation | TPLHLAASHGHRDIV CCHHHHHHCCCHHHH | 25.13 | - | |
85 | Ubiquitination | GHRDIVQKLLQYKAD CCHHHHHHHHHHHCH | 40.03 | 21890473 | |
85 | Ubiquitination | GHRDIVQKLLQYKAD CCHHHHHHHHHHHCH | 40.03 | 21890473 | |
85 | Ubiquitination | GHRDIVQKLLQYKAD CCHHHHHHHHHHHCH | 40.03 | 21890473 | |
86 | Ubiquitination | HRDIVQKLLQYKADI CHHHHHHHHHHHCHH | 1.69 | - | |
132 | Phosphorylation | LVSICNKYGEMPVDK HHHHHHHCCCCCHHH | 12.34 | 29496907 | |
139 | Ubiquitination | YGEMPVDKAKAPLRE CCCCCHHHCHHHHHH | 52.61 | 21906983 | |
141 | Ubiquitination | EMPVDKAKAPLRELL CCCHHHCHHHHHHHH | 57.17 | - | |
154 | Ubiquitination | LLRERAEKMGQNLNR HHHHHHHHHHCCCCC | 47.55 | - | |
159 | Ubiquitination | AEKMGQNLNRIPYKD HHHHHCCCCCCCCCC | 3.33 | 21890473 | |
164 | Phosphorylation | QNLNRIPYKDTFWKG CCCCCCCCCCCCCCC | 21.08 | 23312004 | |
165 | Ubiquitination | NLNRIPYKDTFWKGT CCCCCCCCCCCCCCC | 44.96 | 21890473 | |
165 | Ubiquitination | NLNRIPYKDTFWKGT CCCCCCCCCCCCCCC | 44.96 | 21890473 | |
165 | Malonylation | NLNRIPYKDTFWKGT CCCCCCCCCCCCCCC | 44.96 | 26320211 | |
167 | Phosphorylation | NRIPYKDTFWKGTTR CCCCCCCCCCCCCCC | 27.52 | 28857561 | |
170 | Acetylation | PYKDTFWKGTTRTRP CCCCCCCCCCCCCCC | 42.03 | 27452117 | |
170 | Methylation | PYKDTFWKGTTRTRP CCCCCCCCCCCCCCC | 42.03 | 30781615 | |
170 | Ubiquitination | PYKDTFWKGTTRTRP CCCCCCCCCCCCCCC | 42.03 | 21906983 | |
172 | Phosphorylation | KDTFWKGTTRTRPRN CCCCCCCCCCCCCCC | 14.91 | 23403867 | |
173 | Phosphorylation | DTFWKGTTRTRPRNG CCCCCCCCCCCCCCC | 38.42 | 23403867 | |
175 | Phosphorylation | FWKGTTRTRPRNGTL CCCCCCCCCCCCCCC | 42.82 | 30242111 | |
181 | Phosphorylation | RTRPRNGTLNKHSGI CCCCCCCCCCCCCCC | 30.61 | 23401153 | |
184 | Ubiquitination | PRNGTLNKHSGIDFK CCCCCCCCCCCCCHH | 42.11 | - | |
186 | Phosphorylation | NGTLNKHSGIDFKQL CCCCCCCCCCCHHHH | 38.77 | 30266825 | |
191 | Sumoylation | KHSGIDFKQLNFLTK CCCCCCHHHHHHHHH | 50.56 | - | |
191 | Ubiquitination | KHSGIDFKQLNFLTK CCCCCCHHHHHHHHH | 50.56 | 21890473 | |
191 | Sumoylation | KHSGIDFKQLNFLTK CCCCCCHHHHHHHHH | 50.56 | - | |
191 | Ubiquitination | KHSGIDFKQLNFLTK CCCCCCHHHHHHHHH | 50.56 | 21906983 | |
197 | Phosphorylation | FKQLNFLTKLNENHS HHHHHHHHHCCCCCC | 29.37 | 23312004 | |
198 | Ubiquitination | KQLNFLTKLNENHSG HHHHHHHHCCCCCCC | 52.00 | 21906983 | |
204 | Phosphorylation | TKLNENHSGELWKGR HHCCCCCCCCCCCCE | 45.61 | 24719451 | |
207 | Ubiquitination | NENHSGELWKGRWQG CCCCCCCCCCCEECC | 6.99 | - | |
209 | Ubiquitination | NHSGELWKGRWQGND CCCCCCCCCEECCCC | 51.74 | 21906983 | |
220 | Ubiquitination | QGNDIVVKVLKVRDW CCCCEEEEEEEECCC | 30.84 | 21890473 | |
220 | Ubiquitination | QGNDIVVKVLKVRDW CCCCEEEEEEEECCC | 30.84 | 21890473 | |
228 | Phosphorylation | VLKVRDWSTRKSRDF EEEECCCCCCCCCCC | 23.71 | 28060719 | |
229 | Phosphorylation | LKVRDWSTRKSRDFN EEECCCCCCCCCCCC | 37.55 | 28060719 | |
232 | Phosphorylation | RDWSTRKSRDFNEEC CCCCCCCCCCCCCCC | 33.52 | 27794612 | |
246 | Phosphorylation | CPRLRIFSHPNVLPV CCCEEEECCCCCCCC | 35.35 | 22817900 | |
292 | Ubiquitination | TNFVVDQSQAVKFAL CCEEECHHHHHHHHH | 18.68 | - | |
292 | Acetylation | TNFVVDQSQAVKFAL CCEEECHHHHHHHHH | 18.68 | - | |
304 | Ubiquitination | FALDMARGMAFLHTL HHHHHHHHHHHHHHH | 11.39 | - | |
314 | Ubiquitination | FLHTLEPLIPRHALN HHHHHCCCCCHHHHC | 6.51 | - | |
318 | Ubiquitination | LEPLIPRHALNSRSV HCCCCCHHHHCCCCE | 29.25 | - | |
324 | Phosphorylation | RHALNSRSVMIDEDM HHHHCCCCEEECCCC | 18.83 | 30206219 | |
326 | Sulfoxidation | ALNSRSVMIDEDMTA HHCCCCEEECCCCCE | 3.18 | 30846556 | |
331 | Sulfoxidation | SVMIDEDMTARISMA CEEECCCCCEEEECC | 2.72 | 30846556 | |
332 | Phosphorylation | VMIDEDMTARISMAD EEECCCCCEEEECCC | 25.71 | 30206219 | |
336 | Phosphorylation | EDMTARISMADVKFS CCCCEEEECCCEEEE | 11.45 | 30206219 | |
341 | Ubiquitination | RISMADVKFSFQCPG EEECCCEEEEEECCC | 35.52 | - | |
343 | Phosphorylation | SMADVKFSFQCPGRM ECCCEEEEEECCCCC | 14.53 | 11313365 | |
351 | Phosphorylation | FQCPGRMYAPAWVAP EECCCCCEECEEECH | 14.20 | 27642862 | |
363 | Ubiquitination | VAPEALQKKPEDTNR ECHHHHHCCCCCCCC | 71.76 | - | |
377 | Ubiquitination | RRSADMWSFAVLLWE CCCHHHHHHHHHHHH | 9.18 | 21890473 | |
398 | Sulfoxidation | PFADLSNMEIGMKVA CHHHCCCCHHHHHHH | 3.40 | 30846556 | |
402 | Sulfoxidation | LSNMEIGMKVALEGL CCCCHHHHHHHHCCC | 3.76 | 30846556 | |
423 | Acetylation | GISPHVCKLMKICMN CCCHHHHHHHHHHHC | 50.99 | 25953088 | |
423 | Malonylation | GISPHVCKLMKICMN CCCHHHHHHHHHHHC | 50.99 | 26320211 | |
423 | Ubiquitination | GISPHVCKLMKICMN CCCHHHHHHHHHHHC | 50.99 | - | |
426 | Acetylation | PHVCKLMKICMNEDP HHHHHHHHHHHCCCH | 43.09 | 23954790 | |
426 | Ubiquitination | PHVCKLMKICMNEDP HHHHHHHHHHHCCCH | 43.09 | - | |
426 | Malonylation | PHVCKLMKICMNEDP HHHHHHHHHHHCCCH | 43.09 | 26320211 | |
429 | Sulfoxidation | CKLMKICMNEDPAKR HHHHHHHHCCCHHHC | 7.58 | 30846556 | |
435 | Ubiquitination | CMNEDPAKRPKFDMI HHCCCHHHCCCCCCH | 74.70 | - | |
438 | Ubiquitination | EDPAKRPKFDMIVPI CCHHHCCCCCCHHHH | 59.01 | 21890473 | |
438 | Ubiquitination | EDPAKRPKFDMIVPI CCHHHCCCCCCHHHH | 59.01 | 21890473 | |
448 | Ubiquitination | MIVPILEKMQDK--- CHHHHHHHHHCC--- | 38.11 | 21906983 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
173 | T | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
173 | T | Phosphorylation | Kinase | PAK1 | Q13153 | PSP |
181 | T | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
246 | S | Phosphorylation | Kinase | PAK1 | Q13153 | PSP |
343 | S | Phosphorylation | Kinase | ILK | Q13418 | PhosphoELM |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ILK_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ILK_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...